Lloyd Rowland

Insider Reports History

Entity
Individual
Location
Amylin Pharmaceuticals Inc, 9360 Towne Centre Dr, San Diego, CA
Signature
/s/ Lloyd Rowland
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lloyd Rowland:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. General Counsel Common Stock 131K $161K $1.23 Aug 20, 2024 Direct
CytomX Therapeutics, Inc. General Counsel Performance Stock Units (PSUs) 0 $0 $1.23 Aug 20, 2024 Direct
CytomX Therapeutics, Inc. General Counsel Stock Option (Right to Buy) 100K Jan 18, 2024 Direct

Insider Reports Filed by Lloyd Rowland

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTMX CytomX Therapeutics, Inc. Aug 20, 2024 3 -$5.14K 4 Aug 22, 2024 General Counsel
CTMX CytomX Therapeutics, Inc. Mar 19, 2024 1 -$11K 4 Mar 21, 2024 General Counsel
CTMX CytomX Therapeutics, Inc. Jan 18, 2024 3 $0 4 Jan 19, 2024 General Counsel
CTMX CytomX Therapeutics, Inc. Dec 20, 2023 1 -$5.63K 4 Dec 22, 2023 General Counsel
CTMX CytomX Therapeutics, Inc. Dec 17, 2023 2 $0 4 Dec 19, 2023 General Counsel
CTMX CytomX Therapeutics, Inc. Sep 20, 2023 2 -$7.14K 4 Sep 22, 2023 General Counsel
CTMX CytomX Therapeutics, Inc. Mar 16, 2023 1 -$4.03K 4 Mar 20, 2023 General Counsel
CTMX CytomX Therapeutics, Inc. Feb 2, 2023 3 $0 4 Feb 6, 2023 General Counsel
CTMX CytomX Therapeutics, Inc. Aug 10, 2022 2 $0 4 Aug 12, 2022 General Counsel
CTMX CytomX Therapeutics, Inc. Jul 19, 2022 2 -$7.97K 4 Jul 21, 2022 General Counsel
CTMX CytomX Therapeutics, Inc. Feb 2, 2022 2 $0 4 Feb 4, 2022 General Counsel
CTMX CytomX Therapeutics, Inc. Oct 24, 2021 2 $0 4 Oct 26, 2021 General Counsel